2004•Journal of Bone and Mineral MetabolismRequires access

Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline

Reiko Okabe, Masaaki Inaba, Kiyoshi Nakatsuka, Takami Miki, Hiroshi Naka, Atushi Moriguchi, Yoshiki Nishizawà

Open publisher page 44 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 44 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Deoxypyridinoline, N-terminal telopeptide, Pyridinoline, Internal medicine, Bone resorption, Bone remodeling, Endocrinology, Medicine

Back to paper search Browse research topics Original source

Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline — Research Paper | ScholarLens